Remove bio-health
article thumbnail

Surya Ganguli, Bio + Health Venture Partner

Andreessen Horowitz

At a16z Bio + Health, we are constantly looking to expand our expertise and partnerships in service of our mission to support founders pioneering transformative healthcare solutions. Please join us in welcoming Surya Ganguli to a16z Bio + Health.

article thumbnail

AI at the Intersection: The a16z Investment Thesis on AI in Bio + Health

Andreessen Horowitz

This … The post AI at the Intersection: The a16z Investment Thesis on AI in Bio + Health appeared first on Andreessen Horowitz. A Tale of Two Exponentials Harnessing Moore to combat Eroom Computers today are roughly 1000x more powerful, at the same price, than those a decade ago.

AI 116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Will Shrank, Bio + Health Advisory Partner

Andreessen Horowitz

To do that well requires a deep understanding of the industry’s esoteric nuance and unintuitive … The post Will Shrank, Bio + Health Advisory Partner appeared first on Andreessen Horowitz.

article thumbnail

Greg Verdine, Bio + Health Venture Partner

Andreessen Horowitz

As we strive to find and support the most ambitious life sciences founders, we also work to connect these founders with exceptional advisors who have traveled the … The post Greg Verdine, Bio + Health Venture Partner appeared first on Andreessen Horowitz.

Travel 61
article thumbnail

New Year, New Fund, New Opportunities in Bio + Health

Andreessen Horowitz

2021 saw higher than ever funding of startups, continued maturation of the tech-enabled bio and healthcare landscape, and new platforms and business models that propelled growing levels of adoption and scale amongst both upstarts and traditional players.

article thumbnail

SaaS and Supply Chains (Bio + Health Newsletter November 2022)

Andreessen Horowitz

As much as we hem and haw about the adoption of value-based care being slow, the fact is … The post SaaS and Supply Chains (Bio + Health Newsletter November 2022) appeared first on Andreessen Horowitz. “The future is already here – it’s just unevenly distributed,” said science fiction writer William Gibson.

SaaS 89
article thumbnail

The Power of Drug Discovery with Philip Tagari

Andreessen Horowitz

Philip Tagari, Chief Scientific Officer of insitro, joins Vijay Pande, founding general partner at a16z Bio + Health. Together, they discuss the transformative power of drugs in changing human health—and history. Finally, they chat about where the industry is headed, and how AI might change the competition landscape.

AI 88